A tale of two sexually transmitted diseases: Prevalences and predictors of chlamydia and gonorrhea in women attending Colorado family planning clinics

Sexually Transmitted Diseases

Volumn 23, Issue 6, 1996, Pages 481-488

  Gershman, Kenneth A ^a   Barrow, Jennifer C ^a  

^a Colorado Dept Pub Hlth Environ ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CHLAMYDIASIS; ETHNIC DIFFERENCE; FAMILY PLANNING; FEMALE; GONORRHEA; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UNITED STATES;

EID: 0029822007     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199611000-00008     Document Type: Article

References (34)

1. Washington AE, Johnson RE, Sanders LL, et al. Incidence of Chlamydia trachomatis infections in the United States: Using reported Neisseria gonorrhoeae as a surrogate. In: Oriel JD, Ridgway GL, Schachter J, et al, eds. Chlamydia trachomatis Infections: Proceedings of Sixth International Symposium on Human Chlamydia trachomatis Infections. New York: Cambridge University Press, 1986; 487-490.
2. Division of STD Prevention. Sexually Transmitted Disease Surveillance, 1994. US Department of Health and Human Services, Public Health Service. Atlanta: Centers for Disease Control and Prevention. September 1995.
3. Stamm WE, Holmes KK. Chlamydia trachomatis infections of the adult. In: Holmes KK, Mårdh P-A, Sparling PF, Wiesner PJ, eds. Sexually Transmitted Diseases. New York: McGraw-Hill, 1990; 181-194.
4. Westrom L, Mårdh P-A. Acute pelvic inflammatory disease. In: Holmes KK, Mårdh P-A, Sparling PF, Wiesner PJ, eds. Sexually Transmitted Diseases. New York: McGraw-Hill, 1990; 593-613.
5. Gershman KA, Rolfs RT. Diverging gonorrhea and syphilis trends in the 1980s: Are they real? Am J Public Health 1991; 81:1263-1267.
6. Britton TF, DeLisle S, Fine DF. STDs and family planning clinics: A regional program for chlamydia control that works. Am J Gynecol Health 1992; 6:80-87.
7. Centers for Disease Control. Chlamydia prevalence and screening practices - San Diego County, California, 1993. MMWR 1994; 43:366-369.375.
8. Adiss DG, Vaughn ML, Ludka D, Pfister J, Davis JP. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin. Sex Transm Dis 1993; 20:28-35.
9. Hook EW, Reichart CA, Upchurch DM, Ray P, Celentano D, Quinn TC. Comparative behavioral epidemiology of gonoccocal and chlamydial infections among patients attending a Baltimore, Maryland, sexually transmitted disease clinic. Am J Epidemiol 1992; 136:662-672.
10. Hart G. Factors associated with genital chlamydial and gonoccocal infections in females. Genitourin Med 1992; 68:217-220.
11. Jolly AM, Orr PH, Hammond G, Young TK. Risk factors for infection in women undergoing testing for Chlamydia trachomatis and Neisseria gonorrhoeae in Manitoba, Canada. Sex Transm Dis 1995; 22:289-295.
12. Vincelette J, Baril JG, Allard R. Predictors of chlamydial infection and gonorrhea among patients seen by private practitioners. Can Med Assoc J 1991; 144:713-721.
13. Humphreys JT, Henneberry JF, Rickard RS, Beebe JL. Cost-benefit analysis of selective screening criteria for Chlamydia trachomatis infection in women attending Colorado family planning clinics. Sex Transm Dis 1992; 19:47-53.
14. Hillis S, Black C, Newhall J, Walsh C, Groseclose SL. New opportunities for chlamydia prevention: Applications of science to public health practice. Sex Transm Dis 1995; 22:197-202.
15. SAS-PC Release 6.04. Cary, NC: SAS Institute, 1987.
16. Epi Info Version 6. Atlanta, GA: Centers for Disease Control, 1994.
17. Egret Statistical Package. Seattle, WA: Statistics and Epidemiology Research Corporation, 1995.
18. Handsfield HH, Jasman LL, Roberts PL, Hanson VW, Kothenbeutel RL, Stamm WE. Criteria for selective screening for Chlamvdia trachomatis infection in women attending family planning clinics. JAMA 1986; 255:1730-1734.
19. Winter L, Goldy AS, Baer C. Prevalence and epidemiologic correlates of Chlamydia trachomatis in rural and urban populations. Sex Transm Dis 1990; 17:30-36.
20. Zimmerman HL, Potterat JJ, Dukes RL, et al. Epidemiologic differences between chlamydia and gonorrhea. Am J Public Health 1990; 80:1338-1342.
21. Limberger RJ, Biega R, Evancoe A, McCarthy L, Slivienski L, Kirkwood M. Evaluation of culture and the Gen-Probe PACE 2 assay for detection of Neisseria gonorrhoeae and Chlamydia trachomatis in endocervical specimens transported to a state health laboratory. J Clin Microbiol 1992; 30:1162-1166.
22. Panke ES, Yang LI, Leist PA, Mageuney P, Fry RJ, Lee RF. Comparison of Gen-Probe DNA probe test and culture for the detection of Neisseria gonorrhoeae in endocervical specimens. J Clin Microbiol 1991; 29:883-888.
23. Hale YM, Melton ME, Lewis JS, Willis DE. Evaluation of the PACE 2 Neisseria gonorrhoeae assay by three public health laboratories. J Clin Microbiol 1993; 31:451-453.
24. Stary A, Kopp W, Zahel B, Nerad S, Teodorowicz L, Horting-Muller I. Comparison of DNA-probe test and culture for the detection of Neisseria gonorrhoeae in genital samples. Sex Transm Dis 1993; 20:243-247.
25. Vlaspolder F, Mutsaers JAEM, Blog F, Notowicz A. Value of a DNA probe assay (Gen-Probe) compared with that of culture for diagnosis of gonococcal infection. J Clin Microbiol 1993; 31:107-110.
26. Smith KR, Ching S, Lee H, et al. Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic. J Clin Microbiol 1995; 33:455-457.
27. Pasternack R, Vuorinen P, Kuukankorpi A, Pitkajarvi T, Miettinen A. Detection of Chlamydia trachomatis infections in women by Amplicor PCR: Comparison of diagnostic performance with urine and cervical specimens. J Clin Microbiol 1996; 34:995-998.
28. Miettinen A, Vuorinen P, Varis T, Hallstrom O. Comparison of enzyme immunoassay antigen detection, nucleic acid hybridization and PCR assay in the diagnosis of Chlamydia trachomatis infection. Eur J Clin Microbiol Infect Dis 1995; 14:546-549.
29. Bianchi A, Scieux C, Brunat N, et al. An evaluation of the polymerase chain reaction Amplicor Chlamydia trachomatis in male urine and female urogenital specimens. Sex Transm Dis 1994; 21:196-200.
30. Thejls H, Gnarpe J, Gnarpe H, et al. Expanded gold standard in the diagnosis of Chlamydia trachomatis in a low prevalence popoulation: Diagnostic efficacy of tissue culture, direct immunofluorescence, enzyme immunoassay, PCR and serolosy. Genitourin Med 1994; 70:300-303.
31. Skulnick M, Chua R, Simor A, et al. Use of the polymerase chain reaction for the detection of Chlamydia trachomatis from endocervical and urine specimens in an asymptomatic low-prevalence population of women. Diagn Microbiol Infect Dis 1994; 20:195-201.
32. Bassiri M, Hu HY, Domeika MA, et al. Detection of Chlamydia trachomatis in urine specimens from women by ligase chain reaction. J Clin Microbiol 1995; 33:898-900.
33. Cates W, Weisner PJ. National strategies for control of sexually transmitted diseases: A U.S. perspective. In: Holmes KK. Mårdh P-A, Sparling PF, Weisner PJ, eds. Sexually Transmitted Diseases. New York: McGraw-Hill, 1984:931-941.
34. Celum CL, Fine D, DeLisle S, Mosure DJ, Handsfield HH. Cost-effectiveness of selective vs. universal screening for Chlamydia trachomatis infection in women attending family planning and STD clinics. In: Orfila J, Byrne G, Chernesky MA, et al, eds. Chlamydial Infections: Proceedings of the Eighth International Symposium on Human Chlamydial Infections. Bologna (Italy), Societa Editrice Esculapio, 1994: 63-66.